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ABSTRACT
We describe the case of a 68-year-old man, who presented with an ischemic stroke due to cardiac embolization related to mitral valve 
endocarditis. Blood cultures were always negative and post-operative valve histology did not show microorganisms. The patient also 
presented further recurrent peripheral embolic events. These clinical aspects were the first sign of a pancreas adenocarcinoma, which was 
only diagnosed in the clinical autopsy. In conclusion, these clinical findings of recurrent thromboembolic events with no microorganisms 
isolated suggests the diagnostic of a marantic endocarditis. 
LEARNING POINTS
• Marantic endocarditis is characterized by the deposition of fibrin and thrombi on heart valves in the absence of microorganisms. 
• Is associated with higher incidence of thromboembolic events and most commonly found in patients with neoplasia in post-mortem 
studies.
• It is a diagnostic challenge to distinguish from infective endocarditis and a high clinical suspicion is crucial to confirm the diagnosis. 
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CASE REPORT
A 68-year-old man was admitted to the emergency department of our hospital with 1-hour evolution of left hemiparesis and hypoesthesia, 
left facial paralysis and mild dysarthria. Cranial Computed Tomography (CT) showed aspects suggesting right hemispheric acute ischemic 
stroke. The initial laboratory blood tests revealed a platelet count of 74.000/mm3, which contraindicated the thrombolytic treatment. The 
other lab results were within normal ranges values. Chest X-ray and 12-lead electrocardiography findings were normal.
The patient’s medical history included hypertension, chronic gastritis and small hiatus hernia; he was a former smoker, with moderate 
alcoholic habits. 
To clarify the aetiology of stroke, a transthoracic echocardiography (TTE) was done and revealed a mobile and echodense lesion on the 
atrial surface of posterior mitral valve leaflet suggesting a vegetation. The transesophageal echocardiography (TEE) showed the vegetation 
with 20mm of major diameter, mild mitral regurgitation and no leaflet destruction (Fig. 1). As such, the diagnostic of infective endocarditis 
was admitted and empiric antibiotic therapy was initiated, with gentamicin and vancomycin. Serial blood cultures remained sterile, despite 
the extension of incubation time to 21 days. Serologic tests for atypical microorganisms were negative. The immunologic evaluation was 
unremarkable. 
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The TEE was repeated after 15 days of antibiotic treatment and a growth of vegetation was seen, with a large and mobile vegetation attached 
on posterior and anterior mitral valve leaflets and associated with moderate mitral regurgitation. TEE also showed a suspicion of anterior 
leaflet rupture. Regarding hypothetical fungi infection, we decided to add to treatment amphotericin B due to vegetation morphologic 
aspects. The following day, the patient developed signs of acute upper limb ischemia and underwent vascular surgery (thromboembolectomy). 
The bacterial and mycology exam of thrombus was negative.
At the time, we considered uncontrolled infection with two embolic events and enlarging vegetation, despite the large spectrum antibiotic. 
The patient underwent cardiac surgery with replacement of the mitral valve. The microbiologic test of the valve was negative and 
histopathologic examination revealed vegetation constituted by thrombus. These clinical and pathologic findings suggested non-infective 
thrombotic endocarditis. During the post-operative period (on the 4th day), the patient experienced further thrombotic events, with 
irreversible left lower limb ischemic and distal right foot ischemic. Additionally, there was a clinical decline of hemodynamic instability, 
respiratory and acute renal failure. TEE was performed and showed no prosthesis alterations, including no vegetation. Meanwhile, the 
transaminases raise and cholestasis pattern were observed and elevated plasma levels of CA-125 at 2090 U/mL (normal < 35), CA 15.3 at 
202 U/mL (normal < 31) and CYFRA 21 at 88,9 (<2.1) were detected. Abdominal ultrasonography revealed heterogeneous liver with several 
hipoechogenic images, suggesting infarction or secondary deposits. The patient’s clinical and hemodynamic status worsened and he died on 
9th day post- operation. The clinical autopsy revealed a poorly differentiated ductal adenocarcinoma in the tail of the pancreas, measuring 8 
centimetres. Other relevant findings included: splenic artery invasion by the adenocarcinoma of the pancreas; metastasis in the liver, pleura 
and lungs; and thromboembolic infarctions in multiple organs, such as the kidneys, lungs, brain and heart (Fig. 2).
Figure 2. Enhanced cardiac CT that demonstrates homogenous non-calcified 
plaque in proximal LAD (upper arrow) and segmental PE (lower arrow).
Figure 1. Transesophageal echocardiography showing 
vegetation on the mitral valve.
(a) Apical 4 chamber view on first TEE showing 
hypoechoic and homogenous structure on anterior mitral 
leaflet, although no destruction of the leaflet was observed.
(b) Apical 3 chambers view on second TEE showing enlarging 
of vegetation, which was attached to the anterior and 
posterior mitral leaflets. 
(c) 3D TEE with atrial face of mitral valve view showing the 
vegetation.
Figure 2. Clinical autopsy.
(a) Marantic endocarditis demonstrated by an aseptic 
thrombus on the left, loosely attached to the mitral valve 
leaflet on the right.
(b) Poorly differentiated ductal adenocarcinoma of the 
pancreas invading an islet of Langerhans.
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DISCUSSION
Marantic endocarditis (also known as non-bacterial thrombotic endocarditis) is a rare condition, characterized by the deposition of fibrin 
and platelets on heart valves in the absence of a bloodstream bacterial infection. There is a well-established association between patients 
with neoplasia and higher rates of marantic endocarditis, most often found in autopsy[1,2]. Patients with adenocarcinoma were at a higher risk 
than patients with other malignant processes, especially in cases of pancreatic cancer[3]. The pathogenesis is unclear, with a multifactorial 
mechanism behind the hypercoagulability state[4].
As this case report suggests, the diagnosis of marantic endocarditis can be difficult to establish ante mortem because of the paucity of 
symptoms and can often be confused with culture-negatives infective endocarditis. 
Thus, a high index of clinical suspicion is critical in these patients. Compared to infective endocarditis, there is a greater tendency for 
vegetation to embolize and cause extensive infarction. In this particular case, the patient did not have any past history of neoplasia suspicion 
and general analysis, including liver function tests at the beginning of hospitalization, were normal. However, pancreatic tumour is silent, the 
symptoms appear often in advanced stages and the mucinous histologic type is strongly associated with embolism presentation.
A few comments should be made about how the diagnostic investigation was conducted in this case. First of all, we should not have assumed 
the infective endocarditis as the definitive diagnosis because the serial blood cultures were negative as were the serologic tests for atypical 
microorganisms. Thus, we should have researched other causes of recurrent arterial thromboembolic events. The strong and recognized 
association between cancer and thrombophilia induces a high suspicion of occult neoplasia in this patient. 
Second, other exams could have been performed before the patient underwent cardiac surgery. The initial work-up of an unknown primary 
cancer includes an exhaustive physical examination, blood analysis and a CT scan of the chest, abdomen and pelvis with intravenous contrast. 
This imaging test would have been crucial for the diagnosis of pancreatic cancer in a patient with non-infective endocarditis and recurrent 
thromboembolic events.
Tumor markers were requested after surgery, when the liver tests started to change and some of them were elevated. However, the 
majority of tumor markers have low specificity with a higher percentage of false positives and, for this reason, their use for screening is not 
recommended. They can be used to monitor and establish prognosis in patients with already confirmed cancer.
It is clear that this extended analysis should not have been performed routinely in all patients with stroke but only in patients with poorly 
defined aetiology, and especially in those with non-bacterial endocarditis and new embolic events.
Finally, it is important to highlight that more routine investigation should have been done to be sure of the diagnosis before refering the 
patient to an invasive procedure, such as cardiac surgery.
This case brings forward the importance of the clinician, who no longer presumes that a patient has infective endocarditis but, instead, 
carries out more extensive investigations to look for a potential cause for non-bacterial thrombotic endocarditis.
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